Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIOswitch: Pioglitazone Switch in Type 2 Diabetes
NCT00576784Phase 4Completed
- Sponsor
- IKFE
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by IKFE. Primary endpoint: Proportion of patients with an increase in HbA1c by > 0.5% at 6 months. Started Apr 2005; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00576784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576784.